Currently Enrolling Patients for AUR-201 Clinical Trial for Microtia
Auregen is currently enrolling patients for a clinical trial for stage II-IV microtia, an ultra-rare congenital disorder with limited treatment options. It is a human ear replacement built from the patients own ear cartilage and designed to reflect the evolutionary beauty, adaptability, and complexity of the human ear.
Need to Know . . .
- Now enrolling for ages 12 to 29 years old
- English and Spanish speaking candidates
- Auregen will provide reasonable travel costs, cost of surgery, recovery, office visits and the implant